Flash Finance

Fortis Healthcare LimitedFORTISCorporate

Healthcare Medical Care Facilities Latest results: Mar 2026 14 quarters of data
Consolidated Standalone
₹736.50
MCap ₹55,603 Cr · P/E 241.8
Fortis Healthcare Limited — Stock analysis & AI research Fortis Healthcare Limited — Multibagger AI analysis Fortis Healthcare Limited — Seasonality — best & worst months Fortis Healthcare Limited — Technical indicators & charts Fortis Healthcare Limited — Technical setup — score, trend, support & resistance Fortis Healthcare Limited — Live exchange announcements
📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Mid Cap Stocks List 📈 RSI Oversold Stocks📈 New 52-Week Low Stocks📈 20-Day Breakdown Stocks📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks📈 Stocks Near 52-Week Low 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹461 Cr
Sales · Mar 2026
+18.7% YoY
₹110 Cr
Operating Profit · Mar 2026
+55.0% YoY
23.9%
OPM % · Mar 2026
+30.6% YoY
₹25 Cr
Net Profit · Mar 2026
+159.2% YoY
₹0.33
EPS · Mar 2026
+158.9% YoY

📝 Fortis Healthcare Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Fortis Healthcare Limited reported revenue of ₹461 crore for the quarter ended March 2026 (Q4 FY26), up 18.7% from ₹388 crore in the same quarter last year, and up 4.1% sequentially over the December 2025 quarter.

The company swung to a net profit of ₹25 crore from a net loss of ₹42 crore a year earlier. Earnings per share (EPS) came in at ₹0.33.

Operating profit stood at ₹110 crore — an operating margin (OPM) of 23.9%, compared with 18.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Fortis Healthcare Limited posted revenue of ₹1,793 crore, a growth of 24.0% over FY25, with a net profit of ₹230 crore (up 260.5% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,793 crore with a net profit of ₹230 crore.

Valuation snapshot

At the current price of ₹736.50, FORTIS has a market capitalisation of ₹55,603 crore and a trailing P/E of about 241.8.

Within the Medical Care Facilities industry, it is the 4th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 31.17%, foreign institutional investors (FIIs) 25.20%, domestic institutional investors (DIIs) 32.23%, public shareholders 11.40% of Fortis Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹55,603 Cr
Current Price ?
₹736.5
P/E ?
241.78above ind
Industry P/E ?
56.40
P/B ?
6.02
P/S ?
31.01
P/FCF ?
-292.65
Enterprise Value ?
₹57,681 Cr
EV/EBITDA ?
145.30
PEG ?
4.32
Earnings Yield ?
0.5%
Dividend Yield ?
0.13%
Profitability & Returns
Sales (TTM) ?
₹1,793 Cr
OPM ?
22.1%
Profit after tax (TTM) ?
₹230 Cr
EPS (TTM) ?
₹3.05
ROCE ?
4.0%
ROE ?
2.5%
ROA ?
1.9%
Growth
Sales — latest qtr ?
₹461 Cr
PAT — latest qtr ?
₹25 Cr
YoY qtr sales growth ?
18.7%
YoY qtr profit growth ?
159.2%
Sales growth (3y) ?
19%
Sales growth (5y) ?
23%
Profit growth (3y) ?
56%
Profit growth (5y) ?
52%
Financial Health
Debt ?
₹2,078 Cr
Debt to Equity ?
0.23
Interest Coverage ?
1.3
Current Ratio ?
N/A
Ownership
Promoter holding ?
31.17%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-22.7%
Return 6 months ?
-17.3%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 262277289294291307333357367388433456443461 +18.7% +4.1%
Operating Profit 362835404969586067718810099110 +55.0% +11.1%
Other Income 3330314832323510434254092214 -84.0% -81.0%
Interest 2525232119181716275252515648 -7.5% -14.3%
Depreciation 2929252525262627293130283030 -1.7% +0.0%
Profit Before Tax 243181043690505251-39631353437 +195.1% +8.8%
Net Profit 19213952368274040-42521252825 +159.2% -10.7%
EPS 0.260.030.171.260.300.900.360.520.52-0.560.691.650.380.33 +158.9% -13.2%
OPM % 13.8% 9.9% 12.2% 13.5% 16.8% 22.5% 17.4% 16.8% 18.2% 18.3% 20.3% 21.9% 22.3% 23.9% +30.6% +7.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,446 Cr ₹1,793 Cr ₹1,793 Cr +24.0%
Operating Profit ₹256 Cr ₹397 Cr ₹397 Cr +55.4%
OPM % 17.67% 22.14% 22.14% +25.3%
NPM % 4.41% 12.83% 12.83% +190.9%
Other Income ₹199 Cr ₹157 Cr ₹157 Cr -20.7%
Depreciation ₹113 Cr ₹119 Cr ₹119 Cr +5.1%
Interest ₹112 Cr ₹207 Cr ₹207 Cr +85.1%
EBIT ₹143 Cr ₹278 Cr ₹278 Cr +95.2%
PBT ₹114 Cr ₹269 Cr ₹269 Cr +135.1%
Tax ₹36 Cr ₹10 Cr ₹10 Cr -72.6%
Net Profit ₹64 Cr ₹230 Cr ₹230 Cr +260.5%
EPS ₹0.84 ₹3.05 ₹3.05 +263.1%
Material Cost ₹384 Cr ₹234 Cr ₹234 Cr -38.9%
Employee Cost ₹207 Cr ₹122 Cr ₹122 Cr -41.1%
Extraordinary Items ₹-115 Cr ₹39 Cr ₹39 Cr +133.6%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 755755755755 +0.0%
Reserves 8,2098,3328,3198,474 +1.9%
Borrowings 7856592,0392,078 +1.9%
Other Liabilities 620640887688 -22.4%
Total Liabilities 10,36910,38711,99911,994 -0.0%
Fixed Assets 4924679251,266 +36.9%
CWIP 32604295 +126.2%
Investments 8,8488,83410,17810,072 -1.0%
Other Assets 1,027825853562 -34.1%
Total Assets 10,36910,38711,99911,994 -0.0%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 198218334116 -65.3%
Cash from Investing Activity 20544-1,57211 +100.7%
Cash from Financing Activity -395-2451,276-176 -113.8%
Net Cash Flow 81838-49 -228.9%
Free Cash Flow 14544-31-190 -512.9%
CFO/OP 173%125%130%56% -56.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 34414649 +6.5%
Inventory Days 18151618 +12.5%
Days Payable 572608643399 -37.9%
Cash Conversion Cycle -520-553-581-332 +42.9%
Working Capital Days -24-74-165-139 +15.8%
ROCE % 2%2%3%4% +33.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 31.17%31.17%31.17%31.17%31.17% +0.0%
FIIs 27.18%27.90%27.84%25.98%25.20% -3.0%
DIIs 29.79%29.14%29.33%31.35%32.23% +2.8%
Public 11.87%11.79%11.65%11.50%11.40% -0.9%
No. of Shareholders 2,05,3732,20,7662,33,1562,26,6852,20,743 -2.6%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Fortis Healthcare Limited's revenue in Q4 FY26?
Fortis Healthcare Limited reported revenue of ₹461 crore for the quarter ended March 2026 (Q4 FY26), up 18.7% from ₹388 crore in the same quarter last year, and up 4.1% sequentially over the December 2025 quarter.
What was Fortis Healthcare Limited's net profit in Q4 FY26?
The company swung to a net profit of ₹25 crore from a net loss of ₹42 crore a year earlier. Earnings per share (EPS) came in at ₹0.33.
What is FORTIS's market capitalisation and P/E ratio?
At the current price of ₹736.50, FORTIS has a market capitalisation of ₹55,603 crore and a trailing P/E of about 241.8.
Who owns Fortis Healthcare Limited? (shareholding pattern)
As of Jun 2026, promoters held 31.17%, foreign institutional investors (FIIs) 25.20%, domestic institutional investors (DIIs) 32.23%, public shareholders 11.40% of Fortis Healthcare Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI